Peter Craig Barker

US Patent:

20130317971, Nov 28, 2013

Filed:

Jul 30, 2013

Appl. No.:

13/954559

Inventors:

John Wiley - New York NY, US
Frederick Sturm - Chicago IL, US
Jonathan Kronstein - Elmhurst IL, US
Suzanne Spain - Chicago IL, US
Peter Barker - Chicago IL, US

Assignee:

Chicago Mercantile Exchange Inc. - Chicago IL

International Classification:

G06Q 40/04

US Classification:

705 37

Abstract:

The disclosed embodiments relate to determining a listing date, an expiration date and the cash settlement price of a futures contract, i.e. a Treasury Futures, for the delivery of the most recently issued, referred to as an on-the-run, US treasury Note of a particular maturity by reference to the U.S. Treasury Auction cycle and the difference between a resultant industry surveyed swap rate and a resultant industry surveyed swap spread of the respective tenors (time remaining until maturity) of the on-the-run treasury futures.

US Patent:

45336717, Aug 6, 1985

Filed:

Oct 8, 1982

Appl. No.:

6/433603

Inventors:

Tesfaye Biftu - Westfield NJ
Bruce E. Witzel - Westfield NJ
Peter L. Barker - Westfield NJ

Assignee:

Merck & Co., Inc. - Rahway NJ

International Classification:

C07D20726
A61K 3140

US Classification:

514413

Abstract:

New 5-(2,3-dihydro-1H-pyrrolizin-5-oyl)-, 5-(2,3-dihydro-1H-pyrrolo[2,1-b]thiazol-5-oyl)-, 5-(2,3-dihydro-1H-pyrrolo[2,1-b]imidazol-5-oyl)-, and 5-(2,3-dihydro-1H-pyrrolo[2,1-b]oxazol-5-oyl)-pyrrole-2-alkanoic acid derivatives have been prepared. They are found to be effective inhibitors of platelet aggregation and are analgesic and anti-inflammatory agents with low ulcerogenic side effects.

US Patent:

45365121, Aug 20, 1985

Filed:

Oct 8, 1982

Appl. No.:

6/433339

Inventors:

Tesfaye Biftu - Westfield NJ
Bruce E. Witzel - Westfield NJ
Peter L. Barker - Westfield NJ

Assignee:

Merck & Co., Inc. - Rahway NJ

International Classification:

A61K 3140
C07D48706

US Classification:

514413

Abstract:

New 5-(2,3-dihydro-1H-pyrrolizin-5-oyl)-, 5-(2,3-dihydro-1H-pyrrolo[2,1-b]thiazol-5-oyl)-, 5-(2,3-dihydro-1H-pyrrolo[2,1-b]imidazol-5-oyl)-, and 5-(2,3-dihydro-1H-pyrrolo[2,1-b]oxazol-5-oyl)-derivatives of substituted 2,3-dihydro-1H-pyrrolizine-1-alkanoic or carboxylic acids have been prepared. They are found to be effective inhibitors of platelet aggregation and are analgesic/anti-inflammatory agents with low ulcerogenic side effects.

US Patent:

46803912, Jul 14, 1987

Filed:

Apr 10, 1985

Appl. No.:

6/721811

Inventors:

Raymond A. Firestone - Fanwood NJ
Peter L. Barker - Westfield NJ

Assignee:

Merck & Co., Inc. - Rahway NJ

International Classification:

C07D20508
C07D40104
C07D40304
A61K 31395

US Classification:

540355

Abstract:

New substituted azetidinones are found to be potent elastase inhibitors and thereby useful anti-inflammatory/antidegenerative agents.